Close The Loop (ASX: CLG) is clearly good to the environment, but will the ASX stock be good to shareholders?

Both these stocks have disappointed over the long term, but are showing stronger results recently.

Austco Healthcare (ASX: AHC) has cash on the balance sheet, growing profits, and potential for further growth.

Lindsay Australia (ASX: LAU) and CTI Logistics (ASX: CLX) both showed strong profit growth in H1 FY 2023, but are the stocks cheap?

Both these businesses have significant insider ownership, and a history of long term earnings per share growth.

When the little fish tries to eat the big fish… in hopes of becoming the biggest fish!

Claude, Matt and Andrew interview Pro Medicus CEO Sam Hupert.

These three stocks all experienced strong growth in earnings in H1 FY 2023, and trade on modest multiples, if those earnings are sustained.

ESG investing aims to lower the cost of capital for companies that are good for external stakeholders. But ESG Investing has serious flaws.

Trajan Group (ASX: TRJ) is a profitable founder-led company growing both organically and via acquisition.

The H1 FY 2023 Ebos Group results were strong, thanks to a combination of acquired and organic growth.

SRG Global Ltd (ASX:SRG) H1 FY 2023 Results show a business benefitting from strong demand.

The Cogstate share price plunged after takeover discussions ceased. Then came a trading halt, a guidance cut, and another share price plunge.

The Nanosonics (ASX: NAN) H1 FY 2023 results saw record revenue, improving margins and positive free cash flow.

The H1 FY 2023 Lovisa (ASX: LOV) showed strong profit and revenue growth, but shareholders do take on some risk.

Energy One 2023 half year results showed record revenue, but lower profit, due partly to increased investment in growth.

Data#3 (ASX: DTL) presented record results in H1 FY 2023. Can it match this performance in the second half, and is it still cheap?

Objective Corporation (ASX: OCL) grew revenue by 5.5% but profit before tax declined, as a consequences of ending lumpy license sales.

Netwealth (ASX: NWL) achieved a record profit and funds under administration in H1 FY 2023 however client inflows appear to be slowing.

The H1 FY 2023 Pro Medicus (ASX: PME) Results showed record half year revenue and profit. While the outlook is rosy, cash flow was less ideal.